Abstract
Objective:
The aim of this study was to investigate the CT findings and prevalence of hepatic subcapsular steatosis in patients undergoing peritoneal dialysis with intraperitoneal insulin delivery.
Conclusion:
Hepatic subcapsular steatosis appeared as subcapsular nodules and often rindlike areas of low attenuation in seven (18%) of 39 patients who received intraperitoneal insulin with their peritoneal dialysate. Cessation of intraperitoneal insulin therapy led to reversal of the steatosis in three patients.
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Fat Necrosis / diagnostic imaging*
-
Fat Necrosis / epidemiology
-
Fat Necrosis / etiology*
-
Fatty Liver / diagnostic imaging*
-
Fatty Liver / epidemiology
-
Fatty Liver / etiology*
-
Female
-
Humans
-
Hypoglycemic Agents / administration & dosage*
-
Hypoglycemic Agents / adverse effects*
-
Infusions, Parenteral / adverse effects*
-
Insulin / administration & dosage*
-
Insulin / adverse effects*
-
Kidney Failure, Chronic / complications
-
Kidney Failure, Chronic / diagnostic imaging*
-
Kidney Failure, Chronic / therapy
-
Male
-
Middle Aged
-
Peritoneal Dialysis / adverse effects
-
Prevalence
-
Reproducibility of Results
-
Tomography, X-Ray Computed*
Substances
-
Hypoglycemic Agents
-
Insulin